The pharmaceutical industry demands the highest standards of quality and purity for its raw materials. For the synthesis of Active Pharmaceutical Ingredients (APIs), intermediates like 4-(3-Phenylpropyl)pyridine (CAS 2057-49-0) are indispensable. Understanding the critical factors involved in sourcing this compound, particularly from a reliable pharmaceutical intermediate supplier in China, is essential for successful drug development and manufacturing.

The Significance of 4-(3-Phenylpropyl)pyridine in Pharmaceuticals

4-(3-Phenylpropyl)pyridine, characterized by its CAS number 2057-49-0, is a key building block in the synthesis of various complex organic molecules used in medicinal chemistry. Its specification as a colorless to light yellow liquid with 99% purity makes it suitable for stringent pharmaceutical applications. Its molecular structure, C14H15N, and weight of 197.28 are critical parameters for ensuring consistent reactions and final product efficacy. The compound's utility as a versatile intermediate allows for the creation of novel therapeutic agents, contributing significantly to drug discovery pipelines.

Quality Assurance in Sourcing

When looking to buy 4-(3-Phenylpropyl)pyridine for pharmaceutical use, quality assurance is non-negotiable. Procurement professionals must:

  • Verify Purity: Always request a detailed Certificate of Analysis (CoA) confirming the 99% purity and identifying any potential impurities.
  • Assess Manufacturer Reputation: Partner with established chemical manufacturers that have a proven track record in producing pharmaceutical-grade intermediates.
  • Inquire about Compliance: Ensure the supplier adheres to relevant industry standards and regulatory guidelines.

Cost-Effectiveness and Reliability from Chinese Suppliers

China has become a global leader in chemical manufacturing, offering competitive pricing and robust production capabilities. Sourcing 4-(3-Phenylpropyl)pyridine from a reputable Chinese supplier can provide significant cost advantages without compromising on quality. By obtaining detailed quotes and establishing a strong working relationship, pharmaceutical companies can secure a reliable supply chain for this critical intermediate. This strategic sourcing ensures that production timelines are met and that the high-purity material needed for API synthesis is readily available.

Ultimately, the successful integration of 4-(3-Phenylpropyl)pyridine into pharmaceutical manufacturing relies on a meticulous approach to sourcing. Prioritizing quality, purity, and supply chain reliability from qualified manufacturers ensures that this vital intermediate contributes effectively to the development of life-saving medications.